CSIMarket
 


Instil Bio Inc   (TIL)
Other Ticker:  
 
 

TIL's Net Cash Flow Growth by Quarter and Year

Instil Bio Inc 's Net Cash Flow results by quarter and year




TIL Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 2.03 17.37 1.39
III Quarter September -12.69 -0.78 -546.01 2.41
II Quarter June -5.03 -18.14 -42.58 -3.75
I Quarter March -15.67 23.15 367.85 3.69
FY   -33.39 6.26 -203.37 3.74



TIL Net Cash Flow third quarter 2023 Y/Y Growth Comment
Instil Bio Inc in the third quarter 2023 recorded net cash outflow of $ -12.69 millions.

Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 15 other companies have achieved higher Net Cash Flow growth. While Instil Bio Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 460 in the third quarter 2023.




TIL Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -88.31 % 1149.64 % -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - -93.71 % 9868.83 % -
FY   - - - -

Financial Statements
Instil Bio Inc 's third quarter 2023 Net Cash Flow $ -12.69 millions TIL's Income Statement
Instil Bio Inc 's third quarter 2022 Net Cash Flow $ -0.78 millions Quarterly TIL's Income Statement
New: More TIL's historic Net Cash Flow Growth >>


TIL Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -42.32 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - 33.28 % 26364.03 % -
FY (Year on Year)   - - - -




Net Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #16
Healthcare Sector #77
Overall #460

Net Cash Flow Y/Y Growth Statistics
High Average Low
-245.18 % -3162.19 % -9501.27 %
(Sep 30 2023)   (Sep 30 2021)
Net Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #16
Healthcare Sector #77
Overall #460
Net Cash Flow Y/Y Growth Statistics
High Average Low
-245.18 % -3162.19 % -9501.27 %
(Sep 30 2023)   (Sep 30 2021)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Instil Bio Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TIL's III. Quarter Q/Q Net Cash Flow Comment
Current net cash outflow of -12.69 millions by Instil Bio Inc look even worse considering the -5.03 millions net cash outflow a quarter before.

Within Biotechnology & Pharmaceuticals industry Instil Bio Inc achieved highest sequential Net Cash Flow growth. While Instil Bio Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TIL's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2023 results of -12.69 millions by Instil Bio Inc look even worse considering the -5.03 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Instil Bio Inc achieved highest sequential Net Cash Flow growth. While Instil Bio Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Instil Bio Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ -31.36 $ -19.45 $ -32.56 $ 6.26 $ 21.60
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - -71.01 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 512 # 472 # 430 # 425 # 0




Cumulative Net Cash Flow growth Comment
Instil Bio Inc realized trailing twelve months net cash outflow of $ -31 millions, in the Sep 30 2023, compare to Net Cash Flow of $ 22 millions a year ago.

Instil Bio Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-245.18 %
-3162.19 %
-9501.27 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 82
S&P 500 # 512
Cumulative Net Cash Flow growth Comment
Instil Bio Inc realized trailing twelve months net cash outflow of $ -31 millions, in the Sep 30 2023, compare to Net Cash Flow of $ 22 millions a year ago.

Instil Bio Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-245.18 %
-3162.19 %
-9501.27 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 82
S&P 500 # 512




Other Net Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
TIL's Net Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for TIL's Competitors
Net Cash Flow Growth for Instil Bio Inc 's Suppliers
Net Cash Flow Growth for TIL's Customers

You may also want to know
TIL's Annual Growth Rates TIL's Profitability Ratios TIL's Asset Turnover Ratio TIL's Dividend Growth
TIL's Roe TIL's Valuation Ratios TIL's Financial Strength Ratios TIL's Dividend Payout Ratio
TIL's Roa TIL's Inventory Turnover Ratio TIL's Growth Rates TIL's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2023
Mimedx Group Inc 2,027.83%$ 2,027.832 millions
Rocket Pharmaceuticals Inc 1,877.56%$ 1,877.562 millions
Bionano Genomics Inc 1,857.50%$ 1,857.498 millions
Alpha Pro Tech Ltd 1,508.00%$ 1,508.000 millions
Bridgebio Pharma Inc 1,418.35%$ 1,418.350 millions
Boston Scientific Corporation1,215.38%$ 1,215.385 millions
Vbi Vaccines Inc1,186.44%$ 1,186.444 millions
Shockwave Medical Inc 1,158.53%$ 1,158.535 millions
Heron Therapeutics Inc 1,069.87%$ 1,069.874 millions
Nature s Sunshine Products inc 1,004.06%$ 1,004.063 millions
Glaukos Corp897.67%$ 897.668 millions
West Pharmaceutical Services Inc 874.29%$ 874.286 millions
Eliem Therapeutics Inc 859.28%$ 859.276 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com